Question from Deputy Ken O'Flynn - PQ 39197-26
Deputy O'Flynn asked about whether the treatment abroad scheme is currently subject to any formal risk assessment. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about whether the treatment abroad scheme is currently subject to any formal risk assessment. Read the HSE response.
Deputy O'Flynn asked about any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about assessment regarding legal, safeguarding or governance implications of overseas referrals involving minors. Read the HSE response.
Deputy Rice asked about the reimbursement of Risdiplam for adults living with spinal muscular atrophy. Read the HSE response.
Deputy O'Flynn asked about if a process exists for treatment abroad scheme cases exceeding specified expenditure thresholds. Read the HSE response.
Deputy O'Flynn asked about the appropriateness of relying primarily on referring consultants for overseas treatment selection. Read the HSE response.
Deputy O'Flynn asked about the clinical impact of reimbursement delays for patients with progressive neurological conditions. Read the HSE response.
Deputy Nolan asked about data on termination of pregnancies and the palliative care protocols applied in such cases. Read the HSE response.
Deputy O'Flynn asked if if a public awareness campaign relating to tick-borne illnesses and lyme disease has been undertaken since 2020. Read the HSE response.
Deputy O'Flynn asked about the staffing levels in the health service. Read the HSE response.